JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EOCW
3876
DELISTED
Elliott Opportunity II Corp.
EOCW
| $1M | ﹤0.01% |
+103,385
| New | +$1.01M |
2022 Q2
0 quarters
|
|
3877
Suburban Propane Partners
SPH
$1.11B
| $1M | ﹤0.01% |
65,800
-78,412
| -54% | -$1.3M |
2013 Q2
36 quarters
|
|
|
HAIAU
3878
DELISTED
Healthcare AI Acquisition Corp. Unit
HAIAU
| $1M | ﹤0.01% |
+100,000
| New | +$999K |
2022 Q2
0 quarters
|
|
3879
Fidelity High Dividend ETF
FDVV
$10.2B
| $1M | ﹤0.01% |
27,905
-1,069
| -4% | -$41.8K |
2019 Q4
10 quarters
|
|
|
LAZR
3880
PUT
DELISTED
Luminar Technologies
LAZR
| $1M | ﹤0.01% |
11,267
+7,580
| +206% | +$1.21M |
2022 Q1
1 quarter
|
|
3881
Revolve Group
RVLV
$1.48B
| $1M | ﹤0.01% |
38,692
+10,549
| +37% | +$390K |
2019 Q4
10 quarters
|
|
|
MTRY
3882
DELISTED
Monterey Innovation Acquisition Corp. Common Stock
MTRY
| $1M | ﹤0.01% |
+100,000
| New | +$1M |
2022 Q2
0 quarters
|
|
|
IQMD
3883
DELISTED
Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
| $1M | ﹤0.01% |
100,000
-98,900
| -50% | -$989K |
2022 Q1
1 quarter
|
|
3884
CALL
Clorox
CLX
$9.72B
| $1M | ﹤0.01% |
+7,100
| New | +$1.01M |
2022 Q2
0 quarters
|
|
|
ADRT.U
3885
DELISTED
Ault Disruptive Technologies Corporation Units, each consisting of one share of Common Stock, and three-fourths of one Redeemable Warrant to purchase one share of Common Stock
ADRT.U
| $1M | ﹤0.01% |
100,000
-150,000
| -60% | -$1.5M |
2021 Q4
2 quarters
|
|
|
LFAC
3886
DELISTED
LF Capital Acquisition Corp. II Class A Common Stock
LFAC
| $999K | ﹤0.01% |
+100,000
| New | +$999K |
2022 Q2
0 quarters
|
|
|
AERT
3887
Aeries Technology
AERT
$40M
| $997K | ﹤0.01% |
+12,500
| New | +$986K |
2022 Q2
0 quarters
|
|
|
RBAC
3888
DELISTED
RedBall Acquisition Corp.
RBAC
| $996K | ﹤0.01% |
100,000
| – | – |
2021 Q1
5 quarters
|
|
3889
ProKidney
PROK
$359M
| $995K | ﹤0.01% |
100,000
-310,356
| -76% | -$3.07M |
2022 Q1
1 quarter
|
|
|
JWAC
3890
DELISTED
Jupiter Wellness Acquisition Corp. Class A Common Stock
JWAC
| $995K | ﹤0.01% |
+100,000
| New | +$995K |
2022 Q2
0 quarters
|
|
|
CRHC
3891
DELISTED
Cohn Robbins Holdings Corp.
CRHC
| $994K | ﹤0.01% |
100,000
-716,042
| -88% | -$7.11M |
2021 Q1
5 quarters
|
|
3892
Envoy Medical
COCH
$52.5M
| $991K | ﹤0.01% |
101,079
-46,185
| -31% | -$452K |
2021 Q2
4 quarters
|
|
|
LPRO
3893
DELISTED
Open Lending Corp
LPRO
| $991K | ﹤0.01% |
96,925
-2,203
| -2% | -$29.5K |
2020 Q4
6 quarters
|
|
|
ARR
3894
Armour Residential REIT
ARR
$1.92B
| $988K | ﹤0.01% |
28,033
-12,816
| -31% | -$475K |
2015 Q3
27 quarters
|
|
|
FSRX
3895
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $988K | ﹤0.01% |
+100,848
| New | +$988K |
2022 Q2
0 quarters
|
|
|
ZING
3896
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $988K | ﹤0.01% |
99,925
-50,075
| -33% | -$494K |
2022 Q1
1 quarter
|
|
|
NOAC
3897
DELISTED
Natural Order Acquisition Corp. Common Stock
NOAC
| $988K | ﹤0.01% |
100,000
-96,174
| -49% | -$948K |
2022 Q1
1 quarter
|
|
3898
S&T Bancorp
STBA
$1.75B
| $986K | ﹤0.01% |
35,925
-66,376
| -65% | -$1.88M |
2013 Q2
36 quarters
|
|
3899
CALL
SolarEdge
SEDG
$2.04B
| $985K | ﹤0.01% |
3,600
| – | – |
2022 Q1
1 quarter
|
|
|
ENER
3900
DELISTED
Accretion Acquisition Corp
ENER
| $985K | ﹤0.01% |
100,000
-56,000
| -36% | -$551K |
2021 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.